RT‒qPCR, western blot analysis, and IHC staining were performed to evaluate STARD4 expression, while Kaplan–Meier survival analysis, Gleason score, and tumor stage were performed to assess its clinical significance in PCa. The gene discussed is STARD4; the disease is posterior cortical atrophy.